Periodic Reporting for period 2 - Impentri (First effective pharmacotherapy for ARDS to lower mortality and improve quality of life of patients.)

The overall objective of this project was to establish a clinical trial in India, to evaluate intravenous imatinib (Impentri®) for the treatment of critically ill patients with COVID-19 induced Acute Respiratory Distress Syndrome (ARDS). Based on the results of these studies...